Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableLooking for participantsNCT06035874
What this trial is testing

Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNon Alcholic Fatty Liver Disease
Medanta, The Medicity, India 100
Not applicableStudy completedNCT04698486
What this trial is testing

Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLD

Who this might be right for
NAFLD - Non-Alcoholic Fatty Liver DiseaseType 2 Diabetes
University of Aarhus 17
Not applicableStudy completedNCT01492283
What this trial is testing

Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

Who this might be right for
Non Alcoholic Fatty Liver DiseaseType 2 DiabetesLiver Cirrhosis
University Hospital, Gentofte, Copenhagen 48
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Not applicableUnknownNCT03525769
What this trial is testing

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University 10,000
Not applicableUnknownNCT05422092
What this trial is testing

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Post-approval studies (Phase 4)Looking for participantsNCT06449833
What this trial is testing

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Who this might be right for
Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Zhujiang Hospital 100
Very early researchStudy completedNCT02289235
What this trial is testing

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

Who this might be right for
Fatty LiverDiabetes Mellitus, Type 2
Shiraz University of Medical Sciences 76
Testing effectiveness (Phase 2)WithdrawnNCT02769091
What this trial is testing

A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes

Who this might be right for
Nonalcoholic SteatohepatitisType 2 Diabetes Mellitus
Teva Branded Pharmaceutical Products R&D, Inc.
Post-approval studies (Phase 4)Ended earlyNCT02365233
What this trial is testing

Fatty Liver Study in Patients With Type II Diabetes

Who this might be right for
Type II DiabetesNonalcoholic Fatty Liver
The University of Texas Medical Branch, Galveston 5
Testing effectiveness (Phase 2)Study completedNCT00501592
What this trial is testing

Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Who this might be right for
Diabetes Mellitus, Type IIFatty Liver
Intercept Pharmaceuticals 64
Testing effectiveness (Phase 2)UnknownNCT05751720
What this trial is testing

Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisType 2 Diabetes+1 more
Dr Adnan Agha 30
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60